European universities celebrate their common cultural heritage through European Academic Heritage Day. Stockholm University contributes with two films about the research on the university art collections.
Blue mussels in the Baltic Sea are getting smaller with time but bigger in numbers. It is likely that important functions like filtration of the water has been reduced, which could lead to more turbid water.
Sarahi Garcia’s research goal is to use bacteria as a toolkit for a sustainable world. As someone used to overcoming the odds, for Sarahi education was the key to another life. She is now a fellow at SciLifeLab
For those people who are 70 years or older and live in the same household as someone of working age, the risk of dying in COVID-19 is as much as 60 percent higher. This applies to those who live in Stockholm County.
National research infrastructure resource SciLifeLab is celebrating its tenth anniversary. The facility has an outstanding international reputation and has become a hub for research linked to COVID-19.
Corona related research
Many researchers at the University are doing research related to COVID-19, here you can read about some of them.
Stockholm University takes part in the digital magazine The Conversation where researchers write articles and comment on current news and events. Here you will find our researchers' articles.
Blogs at the University
Here you will find blogs produced at the University. Please let us know about any new blogs or podcasts! firstname.lastname@example.org
In the end of November, the annual list “Highly Cited Researcher-2020” was published. World class researchers are selected for their exceptional research performance and significant influence. This year, eleven researchers from Stockholm University are on the list.
On November 18, European universities celebrate their common cultural heritage through the annual European Academic Heritage Day. This year the day focuses on selected examples from the universities' collections.
Results from Tore Bengtsson’s research group at MBW at Stockholm University has led to the development of novel compounds for the treatment of metabolic diseases such as type 2 diabetes. Atrogi, a company founded on these results, aims to exploit the results to develop novel medicines.